Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, MJ van den Bent, ME Hegi… - The lancet …, 2008 - thelancet.com
Background A randomised trial published by the European Organisation for Research and
Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical …
被引用次数：641 相关文章
[PDF] psu.edu

[PDF][PDF] Nomograms for predicting survival of patients with newly diagnosed glioblastoma: Prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff… - Oncology, 2008 - Citeseer
BACKGROUND: A randomised trial published by the European Organisation for Research
and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) …
[PDF] academia.edu

[PDF][PDF] Nomograms for predicting survival of patients with newly diagnosed glioblastoma: Prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff… - Oncology, 2008 - academia.edu
BACKGROUND: A randomised trial published by the European Organisation for Research
and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) …

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: Prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff… - Lancet …, 2008 - zora.uzh.ch
BACKGROUND: A randomised trial published by the European Organisation for Research
and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) …

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff… - The Lancet …, 2008 - Elsevier
BACKGROUND: A randomised trial published by the European Organisation for Research
and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) …

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3.

T Gorlia, MJ van den Bent, ME Hegi… - The Lancet …, 2007 - europepmc.org
Background A randomised trial published by the European Organisation for Research and
Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical …

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff… - 2008 - pubmed.ncbi.nlm.nih.gov
Background A randomised trial published by the European Organisation for Research and
Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical …

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, MJ van den Bent, ME Hegi… - The Lancet …, 2008 - scholars.northwestern.edu
Background: A randomised trial published by the European Organisation for Research and
Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical …

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, M van den Bent, M Hegi, RO Mirimanoff… - The Lancet …, 2008 - repub.eur.nl
Background: A randomised trial published by the European Organisation for Research and
Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical …

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3

T Gorlia, M van den Bent, ME Hegi… - The Lancet …, 2008 - dial.uclouvain.be
Background A randomised trial published by the European Organisation for Research and
Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical …